Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
2q2z | MKK | Kinesin-like protein KIF11 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
2q2z | MKK | Kinesin-like protein KIF11 | / | 1.000 | |
4a51 | DQ8 | Kinesin-like protein KIF11 | / | 0.623 | |
1q0b | NAT | Kinesin-like protein KIF11 | / | 0.622 | |
2g1q | N9H | Kinesin-like protein KIF11 | / | 0.609 | |
2x7d | EGB | Kinesin-like protein KIF11 | / | 0.578 | |
1x88 | NAT | Kinesin-like protein KIF11 | / | 0.577 | |
2wog | ZZD | Kinesin-like protein KIF11 | / | 0.575 | |
2fme | 3QC | Kinesin-like protein KIF11 | / | 0.565 | |
3k3b | L31 | Kinesin-like protein KIF11 | / | 0.562 | |
4bbg | V02 | Kinesin-like protein KIF11 | / | 0.558 | |
2gm1 | 2AZ | Kinesin-like protein KIF11 | / | 0.552 | |
2x7e | X7E | Kinesin-like protein KIF11 | / | 0.552 | |
2ieh | MOY | Kinesin-like protein KIF11 | / | 0.547 | |
3ken | ZZD | Kinesin-like protein KIF11 | / | 0.539 | |
3k5e | K5E | Kinesin-like protein KIF11 | / | 0.538 | |
2x2r | X2O | Kinesin-like protein KIF11 | / | 0.531 | |
2xae | 2XA | Kinesin-like protein KIF11 | / | 0.526 | |
4a5y | G7X | Kinesin-like protein KIF11 | / | 0.523 | |
2x7c | KZ9 | Kinesin-like protein KIF11 | / | 0.521 | |
4as7 | 6LX | Kinesin-like protein KIF11 | / | 0.492 | |
2yy8 | MTA | tRNA (cytidine(56)-2'-O)-methyltransferase | / | 0.461 | |
3cd5 | 7HI | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.34 | 0.460 | |
4iay | ADP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.460 | |
1c2t | NHS | Phosphoribosylglycinamide formyltransferase | / | 0.458 | |
4ite | TEY | Vitamin D3 receptor | / | 0.457 | |
2gpv | OHT | Estrogen-related receptor gamma | / | 0.454 | |
3qak | UKA | Adenosine receptor A2a | / | 0.454 | |
4z34 | ON7 | Lysophosphatidic acid receptor 1 | / | 0.451 | |
3anm | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.450 | |
1c3e | GAR | Phosphoribosylglycinamide formyltransferase | / | 0.448 | |
3w5t | LHP | Vitamin D3 receptor | / | 0.448 | |
4jhz | 1KV | Beta-glucuronidase | 3.2.1.31 | 0.448 | |
1phe | PIY | Camphor 5-monooxygenase | 1.14.15.1 | 0.447 | |
1uu9 | BI3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
1c2t | GAR | Phosphoribosylglycinamide formyltransferase | / | 0.446 | |
1rfq | LAR | Actin, alpha skeletal muscle | / | 0.446 | |
2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.446 | |
4z35 | ON9 | Lysophosphatidic acid receptor 1 | / | 0.446 | |
1bvr | THT | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.445 | |
3w5p | 4OA | Vitamin D3 receptor | / | 0.445 | |
2qmz | LDP | Ribosyldihydronicotinamide dehydrogenase [quinone] | / | 0.444 | |
4fad | 0TB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
2ham | C33 | Vitamin D3 receptor | / | 0.443 | |
3eb0 | DRK | Uncharacterized protein | / | 0.443 | |
1ikv | EFZ | Gag-Pol polyprotein | 2.7.7.49 | 0.442 | |
2zb4 | 5OP | Prostaglandin reductase 2 | 1.3.1.48 | 0.442 | |
4enh | FVX | Cholesterol 24-hydroxylase | / | 0.442 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
2zxu | DST | tRNA dimethylallyltransferase | 2.5.1.75 | 0.441 | |
3u9e | COA | Lmo1369 protein | / | 0.441 | |
4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.441 | |
1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
1t85 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.440 | |
3s1c | ZIR | Cytokinin dehydrogenase 1 | 1.5.99.12 | 0.440 |